Stephen E. Langille, PhD

FDA/CDER/OPF/DMA
Acting Branch Chief, Division of Microbiology Assessment
Stephen Langille received his B.S. in biology from the University of Massachusetts and his Ph.D. in microbiology from the University of Maryland. He joined the FDA in January of 2000 and now serves as a Branch Chief in the Office of Pharmaceutical Quality’s Division of Microbiology Assessment. He has worked on several USP expert committees to develop and improve compendial standards for visible and sub-visible particulate matter in injectable drug products.